In particular, over-expression of ACSL3 with AMP-binding domain deletion had almost no effect on arachidonic acid and erastin-ferrop, an indication of that maintaining ACSL3 with full biological function at a certain level is beneficial for inducing erastin-ferrop in osteosarcoma cells. This evidence concerns the gene ACSL3 and osteosarcoma.